drugset / Trial / NCT00347841
Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
Non-randomizedSingle-groupOpen-label
Summary
To evaluate the IOP-lowering efficacy of bimatoprost 0.03% in patients found to be low-responders to latanoprost therapy.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 0.03 % | — |
| Background | Latanoprost | Small molecule | — | — |